NEWS
MARKETS
MUTUAL FUNDS
PORTFOLIO
WEALTH
MESSAGES
MY TV
CNBC-TV18 Prime HD
CNBC-TV18
CNBC AWAAZ
CNBC BAJAR
CNBC TV18 SHOWS
VIDEOS
CXO DIALOGUE
Ideas For Profit | Will Sun Pharma’s steady India business, US speciality portfolio help it do well in FY22?
Aug 03, 2020 at 14:57
read news
Like this video, share it with millions of investors on M3
Ideas For Profit | Will Sun Pharma’s steady India business, US speciality portfolio help it do well in FY22?
In this edition of Ideas For Profit, Moneycontrol's Sakshi Batra decodes Sun Pharma Q1 results and suggests what strategy investors could adopt now.
Post your opinion here
0
